核酸污染及其引起呼吸道病毒核酸检测假阳性的鉴定与防范
Identification and Prevention of Nucleic Acid Contamination and the Resultant False Positive Nucleic Acid Tests for Respiratory Viruses
DOI: 10.12677/HJBM.2023.132029, PDF,    国家科技经费支持
作者: 周 纯:金华市人民医院科教科,浙江 金华;陈佑甲, 金志刚*:浙江师范大学生命科学学院,浙江 金华
关键词: 呼吸道病毒新型冠状病毒核酸检测核酸污染假阳性Respiratory Viruses SARS-CoV-2 Nucleic Acid Tests Nucleic Acid Contamination False Positive
摘要: 呼吸道病毒引起的感染性疾病是一类严重威胁人类健康和生命的重大疾病。利用口咽拭子或鼻咽拭子进行呼吸道病原体鉴定,对于病毒性呼吸道感染疾病的临床诊疗和疾病防控均具有重要意义。基于PCR的病毒核酸检测具有操作简便、灵敏度高、特异性强等优点,现已普遍作为病毒病原体鉴定的常用手段。然而由于PCR超高的灵敏度,病毒核酸检测容易因试剂、耗材和环境受到病毒核酸污染而出现假阳性结果,从而影响病原体鉴定的准确性。从事呼吸道病毒研究或检测的科研、医疗工作者由于频繁使用、接触含有病毒核酸序列的表达质粒或阳性对照质粒,其口咽和鼻咽面临核酸污染的高风险,进而在取样口咽拭子或鼻咽拭子进行呼吸道病毒核酸检测时容易出现假阳性。本文以新型冠状病毒为例,分析了核酸污染引起核酸检测假阳性的可能发生情况,并探讨了核酸污染引起核酸检测假阳性的鉴定方法以及预防、消除核酸污染的处理方法,以期减少该类事件的发生,并助力病毒性呼吸道感染的精准诊疗。
Abstract: Infectious diseases caused by respiratory viruses impose a severe threat to human health and life. Identification of the respiratory pathogen using oropharyngeal or nasopharyngeal swabs is essential for clinical diagnosis and treatment of viral respiratory infections, as well as disease control and prevention. PCR-based viral nucleic acid tests have been widely used in identification of viral pathogen due to its advantages in simple operation, high sensitivity and specificity. However, the super-sensitivity of PCR also renders viral nucleic acid tests high incidence of false positive results once the reagents, materials and environments get contaminated with viral nucleic acids, which interferes with the accuracy of pathogen identification. As research and hospital personnel engaged in research or detection of respiratory viruses frequently use or contact with expression plasmids or positive control plasmids that contain viral nucleic acid sequence, their oropharynx and nasopharynx face high risk of nucleic acid contamination, leading to high incidence of false positive results during nucleic acid tests of respiratory viruses using their oropharyngeal or nasopharyngeal swabs. Taking advantage of SARS-CoV-2 as an example, here we analyzed the potential situations that nucleic acid contamination-caused false positive results occur, and discussed how to identify nucleic acid contamination as the cause of false positive results, how to prevent and handle with nucleic acid contamination. We hope this study would be helpful to reduce the incidence of this event and aid precision diagnosis and treatment of viral respiratory infections.
文章引用:周纯, 陈佑甲, 金志刚. 核酸污染及其引起呼吸道病毒核酸检测假阳性的鉴定与防范[J]. 生物医学, 2023, 13(2): 255-262. https://doi.org/10.12677/HJBM.2023.132029

参考文献

[1] 李佩琼. 快速核酸检测常见呼吸道RNA病毒方法的建立及临床应用研究[D]: [博士学位论文]. 广州: 中山大学, 2008.
[2] Colagrossi, L., Mattana, G., Piccioni, L., Cento, V. and Perno, C.F. (2021) Viral Respiratory Infections: New Tools for a Rapid Diagnosis. Seminars in Respiratory and Critical Care Medicine, 42, 747-758. [Google Scholar] [CrossRef] [PubMed]
[3] Beck, I.A., Styrchak, S., Miller, L., et al. (2022) Persistent Nonviral Plasmid Vector in Nasal Tissues Causes False-Positive SARS-CoV-2 Diagnostic Nucleic Acid Tests. Microbiology Spectrum, 10, e0169522. [Google Scholar] [CrossRef] [PubMed]
[4] 陈纯, 董航, 李科, 等. 广州市8起新冠病毒核酸检测假阳性事件原因分析[J]. 国际病毒学杂志, 2022, 29(5): 416-419.
[5] 贾兴旺. 临床实验室新冠核酸检测质量保证及检测能力提升方案[J]. 标记免疫分析与临床, 2022, 29(5): 721-725.
[6] 张礼堃, 邹秉杰. PCR技术在新冠病毒核酸检测中的应用[J]. 医学研究生学报, 2021, 34(5): 539-544.
[7] 侯盼飞, 潘艳, 祝丽晶, 陈小颖. 新冠病毒核酸检测中假阳性问题分析[J]. 中国国境卫生检疫杂志, 2021, 44(5): 373-374.
[8] Rahbari, R., Moradi, N. and Abdi, M. (2021) rRT-PCR for SARS-CoV-2: Analytical Considerations. Clinica Chimica Acta, 516, 1-7. [Google Scholar] [CrossRef] [PubMed]
[9] Roberts, A., Chouhan, R.S., Shahdeo, D., et al. (2021) A Recent Update on Advanced Molecular Diagnostic Techniques for COVID-19 Pandemic: An Overview. Frontiers in Immunology, 12, Article 732756. [Google Scholar] [CrossRef] [PubMed]
[10] Hu, B., Guo, H., Zhou, P. and Shi, Z.-L. (2021) Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19, 141-154. [Google Scholar] [CrossRef] [PubMed]
[11] 刁艳君, 杨柳, 苏明权, 等. SARS-CoV-2实验室核酸检测要点[J]. 检验医学, 2021, 36(3): 352-356.
[12] Pérez-López, B. and Mir, M. (2021) Commercialized Diagnostic Technologies to Combat SARS-CoV2: Advantages and Disadvantages. Talanta, 225, Article ID: 121898. [Google Scholar] [CrossRef] [PubMed]
[13] Parikh, B.A. and Farnsworth, C.W. (2021) Laboratory Evaluation of SARS-CoV-2 in the COVID-19 Pandemic. Best Practice & Research Clinical Rheumatology, 35, Article ID: 101660. [Google Scholar] [CrossRef] [PubMed]
[14] Yoshimoto, F.K. (2020) The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. The Protein Journal, 39, 198-216. [Google Scholar] [CrossRef] [PubMed]
[15] Li, D., Zhang, J. and Li, J. (2020) Primer Design for Quantitative Real-Time PCR for the Emerging Coronavirus SARS-CoV-2. Theranostics, 10, 7150-7162. [Google Scholar] [CrossRef] [PubMed]
[16] Guan, W.-D., Chen, L.-P., Ye, F., Ye, D., Wu, S.-G., Zhou, H.-X., He, J.-Y., Yang, C.-G., Zeng, Z.-Q., Wang, Y.-T., Li, R.-F., Du, Q.-L., Liang, X.-L., Ma, Q.-H. and Yang, Z.-F. (2020) High-Throughput Sequencing for Confirmation of Suspected 2019-nCoV Infection Identified by Fluorescence Quantitative Polymerase Chain Reaction. Chinese Medical Journal, 133, 1385-1386. [Google Scholar] [CrossRef
[17] Zhou, Y., Zhang, L., Xie, Y.-H. and Wu, J. (2022) Advancements in Detection of SARS-CoV-2 Infection for Confronting COVID-19 Pandemics. Laboratory Investigation, 102, 4-13. [Google Scholar] [CrossRef] [PubMed]
[18] Shi, J., Han, D., Zhang, R., Li, J. and Zhang, R. (2020) Molecular and Serological Assays for SARS-CoV-2: Insights from Genome and Clinical Characteristics. Clinical Chemistry, 66, 1030-1046. [Google Scholar] [CrossRef] [PubMed]
[19] Nyaruaba, R., Mwaliko, C., Dobnik, D., Neužil, P., Amoth, P., Mwau, M., Yu, J., Yang, H. and Wei, H. (2022) Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: A Roadmap for Future Outbreaks. Clinical Microbiology Reviews, 35, e0016821. [Google Scholar] [CrossRef] [PubMed]
[20] Liu, X., Feng, J., Zhang, Q., Guo, D., Zhang, L., Suo, T., Hu, W., Guo, M., Wang, X., Huang, Z., Xiong, Y., Chen, G., Chen, Y. and Lan, K. (2020) Analytical Comparisons of SARS-CoV-2 Detection by qRT-PCR and ddPCR with Multiple Primer/Probe Sets. Emerging Microbes & Infections, 9, 1175-1179. [Google Scholar] [CrossRef] [PubMed]
[21] 刘方遥, 于芳, 张恒, 等. 北京市海淀区新型冠状病毒核酸检测实验室污染情况调查与处理[J]. 国际病毒学杂志, 2021, 28(3): 257-260.
[22] 段植, 王琴, 张浩, 周强. 新冠病毒核酸检测实验室核酸污染监测及排除[J]. 中国血液流变学杂志, 2021, 31(4): 553-557.
[23] Banko, A., Petrovic, G., Miljanovic, D., et al. (2021) Comparison and Sensitivity Evaluation of Three Different Commercial Real-Time Quantitative PCR Kits for SARS-CoV-2 Detection. Viruses, 13, Article No. 1321. [Google Scholar] [CrossRef] [PubMed]
[24] 方莉, 刘芷洁, 赵维皎, 许媛. 3种实时荧光PCR试剂在结核分枝杆菌核酸检测中的临床应用评价[J]. 国际检验医学杂志, 2014(8): 977-978
[25] Lippi, G., Simundic, A.-M. and Plebani, M. (2020) Potential Preanalytical and Analytical Vulnerabilities in the Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine, 58, 1070-1076. [Google Scholar] [CrossRef] [PubMed]
[26] 李夫, 张代涛, 贾蕾, 等. 环境样本新型冠状病毒核酸检测阳性结果评估及处置建议[J]. 国际病毒学杂志, 2021, 28(3): 177-181.
[27] 王爽, 潘阳, 徐新民, 等. 新型冠状病毒核酸PCR检测假阳性核酸污染类型的鉴别方法[J]. 首都医科大学学报, 2022, 43(3): 427-432.
[28] 王秋, 黄韵, 姜航, 等. CLSI EP23-A在新型冠状病毒核酸检测实验室风险管理中的应用[J]. 国际检验医学杂志, 2022, 43(21): 2680-2684.
[29] 陈倩, 单志明, 宋超, 等. 浙江地区新建新型冠状病毒核酸检测实验室质量现状分析[J]. 检验医学, 2022, 37(7): 669-673.
[30] 薛秀荣, 来祝檩, 韩惠云. 浅谈核酸检测实验室防污染措施[J]. 中国卫生产业, 2018, 15(26): 144-145.
[31] 姚娜, 潘彤, 赵倩, 等. PCR实验室污染原因分析与排除方法[J]. 继续医学教育, 2019, 33(2): 142-143.
[32] 童永清, 汪明, 徐万洲, 等. 新型冠状病毒核酸检测临床实验室操作规范的建议[J] . 中华检验医学杂志, 2020, 43(3): 209-212.
[33] 李云龙, 张健, 魏艳, 等. 分子诊断实验室去除核酸污染的方法学研究[J]. 生物工程学报, 2021, 37(2): 673-679.
[34] Fischer, M., Renevey, N., Thür, B., Hoffmann, D., Beer, M. and Hoffmann, B. (2016) Efficacy Assessment of Nucleic Acid Decontamination Reagents Used in Molecular Diagnostic Laboratories. PLOS ONE, 11, e0159274. [Google Scholar] [CrossRef] [PubMed]